PMC:7242013 / 11555-11740 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"354","span":{"begin":131,"end":139},"obj":"Species"},{"id":"364","span":{"begin":18,"end":32},"obj":"Disease"}],"attributes":[{"id":"A354","pred":"tao:has_database_id","subj":"354","obj":"Tax:9606"},{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"MESH:D056486"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", or drug‐induced hepatotoxicity. AASLD and APASL provide an algorithm to clinical evaluations (Fig. 1). A key question is whether patients with CLD have a higher risk for severe COVID‐"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T138","span":{"begin":145,"end":148},"obj":"Disease"}],"attributes":[{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0008964"}],"text":", or drug‐induced hepatotoxicity. AASLD and APASL provide an algorithm to clinical evaluations (Fig. 1). A key question is whether patients with CLD have a higher risk for severe COVID‐"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T96","span":{"begin":105,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T97","span":{"begin":154,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":", or drug‐induced hepatotoxicity. AASLD and APASL provide an algorithm to clinical evaluations (Fig. 1). A key question is whether patients with CLD have a higher risk for severe COVID‐"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T45","span":{"begin":5,"end":9},"obj":"Chemical"}],"attributes":[{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":", or drug‐induced hepatotoxicity. AASLD and APASL provide an algorithm to clinical evaluations (Fig. 1). A key question is whether patients with CLD have a higher risk for severe COVID‐"}

{"project":"LitCovid-sentences","denotations":[{"id":"T132","span":{"begin":34,"end":104},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":", or drug‐induced hepatotoxicity. AASLD and APASL provide an algorithm to clinical evaluations (Fig. 1). A key question is whether patients with CLD have a higher risk for severe COVID‐"}